Jiayi Xu

Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.

Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.

Journal: Free radical biology & medicine

Published: July 24, 2025

Stress Granules: Novel Regulators of Programmed Cell Death.

Stress Granules: Novel Regulators of Programmed Cell Death.

Journal: Mini reviews in medicinal chemistry

Published: June 29, 2025

The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma.

The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma.

Journal: Theranostics

Published: April 13, 2025

DNER as a novel protein contributes to HSCR pathogenesis: multi-omics combined Mendelian randomization analysis.

DNER as a novel protein contributes to HSCR pathogenesis: multi-omics combined Mendelian randomization analysis.

Journal: Pediatric research

Published: March 29, 2025

Alexidine dihydrochloride enhances the sensitivity of human hepatocellular carcinoma to disulfidptosis via ATF4-DDIT3 activation.

Alexidine dihydrochloride enhances the sensitivity of human hepatocellular carcinoma to disulfidptosis via ATF4-DDIT3 activation.

Journal: Free radical biology & medicine

Published: March 28, 2025

Lysine β-hydroxybutyrylation in metabolic plasticity and disease pathogenesis.

Lysine β-hydroxybutyrylation in metabolic plasticity and disease pathogenesis.

Journal: The Journal of nutritional biochemistry

Published: March 12, 2025

The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment.

The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 20, 2024

Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.

Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 11, 2024

Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy.

Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy.

Journal: Metabolites

Published: August 31, 2024

Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis.

Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis.

Journal: Cell death & disease

Published: July 31, 2024

Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.

Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.

Journal: Free radical biology & medicine

Published: July 13, 2024

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Journal: Cell biology and toxicology

Published: June 26, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026